Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor α antibody infliximab

Lignende værker

• Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
  af: Baraliakos, X, et al.
  Udgivet: (2005)
• Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes
  af: Baraliakos, X, et al.
  Udgivet: (2007)
• Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis
  af: Rudwaleit, M, et al.
  Udgivet: (2004)
• Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
  af: Baraliakos, X, et al.
  Udgivet: (2005)
• Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
  af: Baraliakos, X, et al.
  Udgivet: (2005)